• Multiple sclerosis: Shall we target cd33? 

      Siokas V., Tsouris Z., Aloizou A.-M., Bakirtzis C., Liampas I., Koutsis G., Anagnostouli M., Bogdanos D.P., Grigoriadis N., Hadjigeorgiou G.M., Dardiotis E. (2020)
      Background: Multiple sclerosis (MS) is a chronic disease of the central nervous system (CNS). Myeloid lineage cells (microglia and macrophages) may participate in the pathogenic mechanisms leading to MS. CD33 is a transmembrane ...
    • Myeloid-derived suppressor cells: Major figures that shape the immunosuppressive and angiogenic network in cancer 

      Vetsika E.-K., Koukos A., Kotsakis A. (2019)
      Myeloid-derived suppressor cells (MDSCs) constitute a vast population of immature myeloid cells implicated in various conditions. Most notably, their role in cancer is of great complexity. They exert immunosuppressive ...